0% found this document useful (0 votes)
41 views11 pages

WHO - Yellow Fever Vaccination Certificates

Yellow fever vaccination certificates have faced procedures and challenges in the region. The WHO recommended countries accelerate control interventions for affected countries, ensure vaccination of travelers to and from affected areas, and intensify surveillance and preparedness in at-risk countries. Additionally, the IHR were amended to accept yellow fever vaccination certificates as valid for life. While yellow fever has not been reported in Southeast Asia, the risk of introduction is greater than ever due to travel and vectors in the region, so countries must maintain outbreak contingency plans.

Uploaded by

Namono Grace
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
41 views11 pages

WHO - Yellow Fever Vaccination Certificates

Yellow fever vaccination certificates have faced procedures and challenges in the region. The WHO recommended countries accelerate control interventions for affected countries, ensure vaccination of travelers to and from affected areas, and intensify surveillance and preparedness in at-risk countries. Additionally, the IHR were amended to accept yellow fever vaccination certificates as valid for life. While yellow fever has not been reported in Southeast Asia, the risk of introduction is greater than ever due to travel and vectors in the region, so countries must maintain outbreak contingency plans.

Uploaded by

Namono Grace
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 11

Yellow Fever Vaccination

Certificates- procedures and


challenges in the region

THE 8TH MEETING OF THE CAPSCA ASIA PACIFIC &


THE 6TH MEETING OF THE CAPSCA GLOBAL PROGRAMME COORDINATION
15-18 NOVEMBER 2016, BANGKOK, THAILAND

Dr Bardan Jung Rana, Regional Adviser


International Health & Regulations (IH&R)
WHO South-East Asia Regional Office (SEARO)
Recent Outbreak
• Yellow Fever (YF) case detected in Luanda, Angola in
December 2015; spread to 14/18 provinces by May 2016
• Exported cases to Democratic Republic of Congo, China &
Kenya
• 7 countries (Peru, Uganda, Brazil, Chad, Colombia, Ghana &
Guinea) reported YF outbreaks/sporadic cases not linked to
Angola outbreak
• No new YF case reported
– in Angola since 23 June 2016
– in DRC since 12 July 2016
• Uganda declared end of YF outbreak on 6 September 2016

International Health & Regulations


WHO South-East Asia Regional Office (SEARO)
2
Emergency Committee
Recommendation
Emphasis on serious national & international
risk of the outbreak
‾ Affected countries: accelerate control
interventions
‾ All countries: ensure YF vaccination of
all travelers to/from affected countries
‾ At risk countries: intensify surveillance &
preparedness, verification of YF
vaccination in travelers, risk
communication
International Health & Regulations
WHO South-East Asia Regional Office (SEARO)
3
YF Strategic Response Framework

International Health & Regulations


WHO South-East Asia Regional Office (SEARO)
4
Yellow Fever Prevention
• YF prevented by an extremely
effective vaccine, which is
safe & affordable
• The vaccine provides effective
immunity within 30 days for
99% of persons vaccinated
• Currently no specific anti-viral
drug for yellow fever
• Good supportive treatment in
hospitals improves survival
rates of those infected with YF

International Health & Regulations


WHO South-East Asia Regional Office (SEARO)
5
International Health Regulations (IHR)
(2005)
Yellow fever – only disease
specified in IHR (2005) for which
countries may require proof of
vaccination from travelers as a
condition of entry under certain
circumstances & may take
certain measures if an arriving
traveler is not in possession of
such a certificate

International Health & Regulations


WHO South-East Asia Regional Office (SEARO)
6
Yellow Fever Vaccination Requirement

International Health & Regulations


WHO South-East Asia Regional Office (SEARO)
7
Fractional dose of YF vaccine
• Due to limited supply of YF vaccine, dose sparing
strategy used to achieve greater coverage
• Fractional dosing using 1/5th of the regular dose
provides effective immunity against YF for at least
12 months & possibly much longer
• Infants/children <2Y require full dose of YF vaccine
as they may have a weaker immune response to the
vaccine than older people
• People receiving fractional dose of YF vaccine are
not entitled to a yellow fever certificate that is
valid for international travel
International Health & Regulations
WHO South-East Asia Regional Office (SEARO)
8
Amendment to Annex 7, IHR (2005)
• A single full dose of yellow fever
vaccine is sufficient to confer
sustained immunity and life-long
protection against YF disease
• Policy of lifetime dose of yellow
fever vaccine came into force
under International Health
Regulations on 11 July 2016
• All countries must accept a YF
yellow fever vaccination
certificate as valid for the life of
the person holding it

International Health & Regulations


WHO South-East Asia Regional Office (SEARO)
9
Yellow Fever in South East Asia (SEA)
• No case of YF reported in the region
• The vector Aedes aegypti endemic in SEA
• YF vaccination recommended to travelers going
to areas at risk of YF
• Travelers arriving from regions with risk of YF
required to present proof of vaccination

International Health & Regulations


WHO South-East Asia Regional Office (SEARO)
10
Yellow Fever threat to SEA

• Risk of introduction of YF
into Asia is now greater
than at any time in history

• Countries need to develop


& keep contingency plans
ready for possible YF
outbreaks

International Health & Regulations


WHO South-East Asia Regional Office (SEARO)
11

You might also like